Cargando…
Menogaril, an Anthracycline Derivative, Inhibits DNA Topoisomerase II by Stabilizing Cleavable Complexes
Menogaril, an anthracycline derivative, has been shown to possess antitumor activity in experimental animal systems, and is now under phase II clinical studies. However, its mechanism of action has not been elucidated. We have found that it inhibits the decatenation activity of purified DNA topoisom...
Autores principales: | Ono, Katsuhiro, Ikegami, Yoji, Nishizawa, Miwako, Andoh, Toshiwo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918973/ https://www.ncbi.nlm.nih.gov/pubmed/1331004 http://dx.doi.org/10.1111/j.1349-7006.1992.tb02016.x |
Ejemplares similares
-
Menogaril, an Anthracycline Compound with a Novel Mechanism of Action: Cellular Pharmacology
por: Wierzba, Konstanty, et al.
Publicado: (1990) -
Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
por: Chan, Agnes L.-F., et al.
Publicado: (2009) -
P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.
por: Badiner, G. J., et al.
Publicado: (1990) -
Response to ICRF-159 in cell lines resistant to cleavable complex-forming topoisomerase II inhibitors.
por: Davies, S. L., et al.
Publicado: (1997) -
Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin‐resistant Subline of Human Colon Carcinoma
por: Yanase, Kae, et al.
Publicado: (2000)